A Risk Score Model Incorporating Three m6A RNA Methylation Regulators and a Related Network of miRNAs-m6A Regulators-m6A Target Genes to Predict the Prognosis of Patients With Ovarian Cancer

Frontiers in Cell and Developmental Biology

Bao-Jin Wang²  Li Yang³  Yuan-Hang Zhu³  Chen-Chen Ren³  Feng Zhang³  Qian Li³  Fei-Yan Li³  Zhen-An Zhang³  Yan-Nan Chen³  Jun Yang³ 

[1] Department of Gynecology, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China;Henan International Joint Laboratory of Ovarian Malignant Tumor, Zhengzhou, China;Henan Province Women and Children’s Hospital, Zhengzhou, China;The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, China;

关键词: ovarian cancer;    m6A;    RNA methylation;    risk model;    prognosis;   

DOI  :  10.3389/fcell.2021.703969

来源: DOAJ

【 摘 要 】

Ovarian cancer (OC) is the leading cause of cancer-related death among all gynecological tumors. N6-methyladenosine (m6A)-related regulators play essential roles in various tumors, including OC. However, the expression of m6A RNA methylation regulators and the related regulatory network in OC and their correlations with prognosis remain largely unknown. In the current study, we obtained the genome datasets of OC from GDC and GTEx database and analyzed the mRNA levels of 21 key m6A regulators in OC and normal human ovarian tissues. The expression levels of 7 m6A regulators were lower in both the OC tissues and the high-stage group. Notably, the 5-year survival rate of patients with OC presenting low VIRMA expression or high HNRNPA2B1 expression was higher than that of the controls. Next, a risk score model based on the three selected m6A regulators (VIRMA, IGF2BP1, and HNRNPA2B1) was built by performing a LASSO regression analysis, and the moderate accuracy of the risk score model to predict the prognosis of patients with OC was examined by performing ROC curve, nomogram, and univariate and multivariate Cox regression analyses. In addition, a regulatory network of miRNAs-m6A regulators-m6A target genes, including 2 miRNAs, 3 m6A regulators, and 47 mRNAs, was constructed, and one of the pathways, namely, miR-196b-5p-IGF2BP1-PTEN, was initially validated based on bioinformatic analysis and assay verification. These results demonstrated that the risk score model composed of three m6A RNA methylation regulators and the related network of miRNAs-m6A regulators-m6A target genes is valuable for predicting the prognosis of patients with OC, and these molecules may serve as potential biomarkers or therapeutic targets in the future.

【 授权许可】

Unknown